Cetera Advisor Networks LLC Astrazeneca PLC Transaction History

Cetera Advisor Networks LLC

$0
Q1 2024

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 14, 2024	BUY	$61.03 - $69.57 $35,031 - $39,933	574 Added 0.92%	63,183 $4.28 Million
Q4 2023 Feb 13, 2024	SELL	$61.89 - $69.28 $84,974 - $95,121	-1,373 Reduced 2.15%	62,609 $4.22 Million
Q3 2023 Nov 14, 2023	BUY	$64.85 - $71.7 $669,251 - $739,944	10,320 Added 19.23%	63,982 $4.33 Million
Q2 2023 Aug 09, 2023	BUY	$69.91 - $75.81 $274,956 - $298,160	3,933 Added 7.91%	53,662 $3.84 Million
Q1 2023 May 15, 2023	BUY	$63.15 - $71.6 $75,148 - $85,204	1,190 Added 2.45%	49,729 $3.45 Million
Q4 2022 Feb 14, 2023	BUY	$54.21 - $70.44 $1.55 Million - $2.01 Million	28,534 Added 142.63%	48,539 $3.29 Million
Q3 2022 Nov 10, 2022	BUY	$53.02 - $135.75 $44,218 - $113,215	834 Added 4.35%	20,005 $1.1 Million
Q2 2022 Aug 11, 2022	SELL	$59.26 - $71.14 $227,321 - $272,893	-3,836 Reduced 16.67%	19,171 $1.27 Million
Q1 2022 May 12, 2022	BUY	$55.72 - $67.12 $111,607 - $134,441	2,003 Added 9.54%	23,007 $1.53 Million
Q4 2021 Feb 14, 2022	SELL	$54.02 - $63.83 $268,155 - $316,852	-4,964 Reduced 19.12%	21,004 $1.22 Million
Q3 2021 Nov 16, 2021	BUY	$55.56 - $60.79 $798,174 - $873,309	14,366 Added 123.82%	25,968 $1.56 Million
Q2 2021 Aug 13, 2021	BUY	$48.42 - $60.18 $170,825 - $212,315	3,528 Added 43.7%	11,602 $695,000
Q1 2021 May 17, 2021	SELL	$47.16 - $54.44 $379,920 - $438,568	-8,056 Reduced 49.94%	8,074 $401,000
Q4 2020 Feb 17, 2021	SELL	$48.52 - $58.02 $56,962 - $68,115	-1,174 Reduced 6.78%	16,130 $806,000
Q3 2020 Nov 13, 2020	BUY	$53.07 - $61.1 $630,259 - $725,623	11,876 Added 218.79%	17,304 $948,000
Q2 2020 Aug 13, 2020	BUY	$43.1 - $55.31 $14,395 - $18,473	334 Added 6.56%	5,428 $287,000
Q1 2020 May 08, 2020	SELL	$37.79 - $51.33 $7,520 - $10,214	-199 Reduced 3.76%	5,094 $228,000
Q4 2019 Feb 10, 2020	BUY	$42.46 - $50.46 $12,653 - $15,037	298 Added 5.97%	5,293 $259,000
Q3 2019 Nov 06, 2019	SELL	$40.12 - $45.47 $23,550 - $26,690	-587 Reduced 10.52%	4,995 $223,000
Q2 2019 Aug 12, 2019	BUY	$37.28 - $41.68 $208,096 - $232,657	5,582 New	5,582 $231,000
Q2 2018 Aug 14, 2018	SELL	$34.55 - $37.05 $202,186 - $216,816	-5,852 Closed	0 $0
Q1 2018 May 09, 2018	SELL	$32.97 - $36.63 $16,485 - $18,315	-500 Reduced 7.87%	5,852 $200,000
Q4 2017 Feb 08, 2018	SELL	$32.09 - $34.78 $10,429 - $11,303	-325 Reduced 4.87%	6,352 $217,000
Q3 2017 Nov 16, 2017	SELL	$28.96 - $34.0 $18,389 - $21,590	-635 Reduced 8.68%	6,677 $224,000
Q2 2017 Aug 14, 2017	BUY	N/A	7,312	7,312 $247,000

Others Institutions Holding AZN

# of Institutions

1,361

Shares Held

475M

Call Options Held

5.39M

Put Options Held

3.75M

Price T Rowe Associates Inc Baltimore, MD

62.9M
Shares

$4.05 Billion
0.56% of portfolio
Primecap Management CO Pasadena, CA

42M
Shares

$2.71 Billion
2.45% of portfolio
Wellington Management Group LLP Boston, MA

37.2M
Shares

$2.4 Billion
0.52% of portfolio
Capital International Investors Los Angeles, CA

36.8M
Shares

$2.37 Billion
0.57% of portfolio
Franklin Resources Inc San Mateo, CA

19.1M
Shares

$1.23 Billion
0.45% of portfolio

View Full List

About ASTRAZENECA PLC

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $200B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

More about AZN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisor Networks LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisor Networks LLC with notifications on news.

Account